Optimizing brain stimulation for epilepsy treatment

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on improving deep brain stimulation (DBS) parameters for patients suffering from medically refractory epilepsy who are not suitable for surgical options. It aims to enhance seizure reduction by fine-tuning the settings of implantable neural stimulators based on individual patient needs. The research will utilize power spectral density measures to create a platform for personalized therapy adjustments. Through this approach, the study seeks to maximize the effectiveness of DBS in achieving better seizure control.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* medically refractory epilepsy
* already have a deep brain stimulator in place

Exclusion Criteria:

* severe dementia at investigator discretion

Where it's running

• University of Minnesota
  Minneapolis, Minnesota, United States Recruiting

Study contacts

• Principal investigator: Robert McGovern, MD — University of Minnesota
• Study coordinator: Anusha Duggirala
• Email: duggi008@umn.edu
• Phone: 612-624-3672

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Biomarker study to predict Vagus Nerve Stimulation response in adults with refractory epilepsy

  This study tests whether biomarkers and network measures can predict how adults with refractory epilepsy will respond to vagus nerve stimulation (VNS) after implantation.

  Recruiting Cliniques universitaires Saint-Luc- Université Catholique de Louvain · Brussels · NCT07909486

• How physical activity might help people with Parkinson’s disease who have DBS-STN implants

  This study tests whether adding regular physical activity can help people with Parkinson’s who have DBS-STN stimulation by trying a structured physiotherapy approach alongside standard care.

  Recruiting Medical University of Warsaw · Warsaw · NCT07838636

• See if deep brain stimulation for Parkinson's changes thinking and movement and affects fall risk

  This pilot study tests whether deep brain stimulation in people with Parkinson’s changes thinking or movement and whether those changes relate to how often they fall.

  Recruiting University of Alabama at Birmingham · Homewood, Alabama · NCT07725315

• Cannabidiol as add-on therapy for children with refractory epilepsy (CBD-uN1que): an individualized N-of-1 series

  This trial tests whether CBD oil helps reduce seizures in children with hard-to-treat epilepsy, using a series of personalized N-of-1 comparisons against a placebo.

  Recruiting Phase 3 UMC Utrecht · Utrecht, Utrecht · NCT07668856

• Real-world use of the OneRF Ablation System for epilepsy

  This registry collects real-world outcomes and device performance from patients with drug-resistant epilepsy who are treated with SEEG-guided RF ablation using the OneRF system.

  Recruiting at 3 sites NeuroOne Medical Technologies Corporation · Miami, Florida and 2 other locations · NCT07546253

• How aerobic exercise (forced vs voluntary cycling) affects movement, thinking, and brain signals in people with Parkinson’s and deep brain stimulation

  This study tests whether forced or voluntary cycling improves movement, thinking, and brain activity in people with Parkinson’s who already have a DBS device.

  Recruiting Phase 2 The Cleveland Clinic · Cleveland, Ohio · NCT07442747

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.